Benutzer: Gast  Login
Dokumenttyp:
journal article 
Autor(en):
Schulz, S; Birkmeier, KA; Ndrepepa, G; Moshage, W; Dotzer, F; Huber, K; Dirschinger, J; Seyfarth, M; Schömig, A; Kastrati, A; Mehilli, J 
Titel:
One-year clinical outcomes with abciximab in acute myocardial infarction: results of the BRAVE-3 randomized trial. 
Abstract:
In the Bavarian Reperfusion Alternatives Evaluation (BRAVE)-3 study upstream administration of abciximab additional to 600 mg clopidogrel loading did not reduce the infarct size in patients with acute ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary interventions. The aim of this study was to investigate 1-year clinical outcomes in the BRAVE-3 study patients.A total of 800 patients with acute STEMI within 24 h from symptom onset, all treated with 600 mg...    »
 
Zeitschriftentitel:
Clin Res Cardiol 
Jahr:
2010 
Band / Volume:
99 
Heft / Issue:
12 
Seitenangaben Beitrag:
795-802 
Sprache:
eng 
Print-ISSN:
1861-0684 
TUM Einrichtung:
I. Medizinische Klinik und Poliklinik